ANN ARBOR, MI--(Marketwire - November 13, 2008) - Adeona Pharmaceuticals, Inc. (AMEX: AEN), a specialty pharmaceutical company developing innovative clinical stage drug candidates for the treatment of autoimmune and central nervous system (CNS), announced that it will host a teleconference call at 4:00 p.m. EST tomorrow to discuss the financial results. Adeona will also provide a review of the Company’s clinical pipeline. There will be a question-and-answer session directly following the presentation of the results.
